Inventor · disambiguated record
Angela Glen
Also filed as: GLEN ANGELA
6 granted patents·4 pending applications·25 citations·filing 2005–2019
77Inventor score
Files withTAKEDA PHARMACEUTICALS CO4BENEVOLENTAI BIO LTD1BENEVOLENTAL BIO LTD1BHALAY GURDIP1NOVARTIS AG1
Top patents by PatentIndex Score
10 records- 0189US9156829B2Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2015·Granted Oct 13, 2015·13 cites·20 claims
- 0286US10011588B21,2-substituted cyclopentanes as orexin receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jul 3, 2018·8 cites·18 claims
- 0379US10689373B21,2-substituted cyclopentanes as orexin receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jun 23, 2020·1 cites·19 claims
- 0473US9790220B2Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Oct 17, 2017·2 cites·12 claims
- 0566US9493432B2Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disordersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Nov 15, 2016·1 cites·15 claims
- 0647US2021253572A1Imidazo[1,2-b]pyridazines as trk inhibitorsBENEVOLENTAL BIO LTD·Filed 2019·Application pending·0 cites
- 0740US2021277008A1Imidazo[1,2-b]pyridazine derivatives as trk inhibitorsBENEVOLENTAI BIO LTD·Filed 2019·Application pending·0 cites
- 0839US7754758B2Pyrrolidine derivatives acting as CCR3-receptor antagonistsNOVARTIS AG·Filed 2005·Granted Jul 13, 2010·0 cites·8 claims
- 0938US2009209522A1Heterocyclic Non-Peptide GNRH AntagonistsSHOWELL GRAHAM ANDREW·Filed 2006·Application pending·0 cites
- 1037US2008096943A1Organic CompundsBHALAY GURDIP·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →